Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A
Date issued
2015Journal title
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Type of content
Publicación de congreso